ARTICLE | Company News
Oxford BioMedica, Clayton Foundation for Research deal
February 1, 2010 8:00 AM UTC
The foundation's technology transfer arm granted Oxford BioMedica exclusive rights to IP covering a method for delivering anti-angiogenic genes to the eye using lentiviral vectors. The foundation will receive an undisclosed upfront payment and is eligible for royalties. Further terms were not disclosed. ...